Orchid Pharma Limited (NSE:ORCHPHARMA)

Orchid Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 11, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	35,678	39,363	52,994	15,643	11,641	98,268
Market Cap Growth	-12.04%	-25.72%	238.77%	34.38%	-88.15%	-
Enterprise Value	37,009	38,574	53,964	18,909	14,449	102,406
Last Close Price	703.45	776.10	1044.85	383.25	285.20	2407.55
PE Ratio	186.59	39.50	57.50	33.77	-	-
PS Ratio	4.40	4.27	6.47	2.35	2.08	21.83
PB Ratio	2.80	3.11	4.53	2.27	1.80	15.05
P/TBV Ratio	2.84	3.15	4.59	2.27	1.80	15.06
P/FCF Ratio	-	-	86.62	-	14.91	427.59
P/OCF Ratio	-	204.86	42.06	85.30	12.59	416.64
EV/Sales Ratio	4.56	4.18	6.59	2.84	2.58	22.75
EV/EBITDA Ratio	82.81	32.97	49.33	22.57	27.21	175.38
EV/EBIT Ratio	-	46.50	69.52	65.22	-	-
EV/FCF Ratio	-	-	88.21	-	18.51	445.59
Debt / Equity Ratio	0.22	0.14	0.12	0.48	0.41	0.69
Debt / EBITDA Ratio	6.52	1.49	1.23	3.96	5.05	7.75
Debt / FCF Ratio	-	-	2.21	-	3.43	19.70
Net Debt / Equity Ratio	0.10	0.12	0.11	0.44	0.41	0.65
Net Debt / EBITDA Ratio	3.11	1.31	1.20	3.64	4.97	7.21
Net Debt / FCF Ratio	-	-1.17	2.15	-4.58	3.38	18.33
Asset Turnover	-	0.57	0.59	0.57	0.48	0.33
Inventory Turnover	-	1.92	2.04	2.00	2.01	1.64
Quick Ratio	-	0.93	0.79	0.65	0.73	1.18
Current Ratio	-	2.83	3.04	1.35	1.65	3.87
Return on Equity (ROE)	-	8.18%	9.92%	7.95%	-9.29%	-13.43%
Return on Assets (ROA)	-	3.20%	3.49%	1.55%	-1.80%	-2.34%
Return on Capital Employed (ROCE)	-	5.90%	6.00%	3.40%	-3.90%	-4.60%
Earnings Yield	0.53%	2.53%	1.74%	2.96%	-0.17%	-1.19%
FCF Yield	-	-3.33%	1.15%	-4.26%	6.71%	0.23%
Buyback Yield / Dilution	0.30%	-4.87%	-18.49%	-	-	-9914.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.